In-Depth Analysis Of The Inherited Retinal Disease Market: Key Drivers, Trends, Growth Opportunities And Forecast 2034

February 25, 2025 05:54 PM AEDT | By EIN Presswire
 In-Depth Analysis Of The Inherited Retinal Disease Market: Key Drivers, Trends, Growth Opportunities And Forecast 2034
Image source: EIN Presswire

The Business Research Company's Inherited Retinal Disease Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034

LONDON, GREATER LONDON, UNITED KINGDOM, February 25, 2025 /EINPresswire.com/ -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Factors Are Driving The Strong Growth Of The Inherited Retinal Disease Market In Recent Years?
The inherited retinal disease market size has experienced substantial growth in recent years. The report anticipates that the market will surge from $11.56 billion in 2024 to $12.58 billion in 2025 at a compound annual growth rate CAGR of 8.8%. Several factors have contributed to this growth, including the adoption of gene therapy, regulatory incentives, growth in patient registries, an increase in clinical trials, and a surge in patient-centric solutions.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20850&type=smp

What Is The Expected Future Growth Of The Inherited Retinal Disease Market And The Key Factors Behind It?
The inherited retinal disease market size is set to witness significant growth in the coming years. The market value is expected to escalate to $17.42 billion in 2029 at a compound annual growth rate CAGR of 8.5%. This growth can be attributed to the increasing use of CRISPR technology, the emergence of personalized treatment, a focus on regenerative medicine, the growth in patient advocacy, and a commitment to improving the quality of life for patients. Major trends in the forecast period include advancements in optogenetics technology, development of artificial retina implants, the broadening of digital health platforms, integration of artificial intelligence in disease modeling, and the application of artificial intelligence in treatment planning.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/inherited-retinal-disease-global-market-report

How Is The Rising Prevalence Of Macular Degeneration Impacting The Inherited Retinal Disease Market?
Macular degeneration, an age-related eye condition that damages the macula, is expected to be a significant driver for the growth of the inherited retinal disease market. The burgeoning prevalence of macular degeneration is owing to aging populations, higher life expectancy, and lifestyle factors such as smoking and poor nutrition. Inherited retinal disease treatment helps macular degeneration patients by targeting the underlying genetic causes of retinal degeneration providing therapies that slow down disease progression, restore lost vision, and even prevent further damage to the retina. Such treatments improve visual outcomes and the quality of life for individuals with age-related or inherited forms of macular degeneration.

Who Are The Key Industry Players In The Inherited Retinal Disease Market?
Major players operating in the inherited retinal disease market include Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, and Endogena Therapeutics.

What Emerging Trends Are Being Noticed In The Inherited Retinal Disease Market?
Companies in the market are emphasizing developing innovative therapies like mutation-agnostic gene therapy to address a wider range of genetic variations associated with these conditions. One such significant advancements in the sector is MCO-010 by Nanoscope Therapeutics Inc, which showed significant vision improvements for patients with severe vision loss from advanced retinitis pigmentosa.

How Is The Inherited Retinal Disease Market Segmented?
1 By Type: Diagnosis, Therapy
2 By Disease Type: Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rode Dystrophy, Leber Congenital Amaurosis, Other Diseases
3 By Distribution Channel: Retail Sales, Direct Tender
4 By End Users: Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Home Healthcare, Other End Users
5 By Diagnosis: Genetic Testing Genetic Screening, Retinal Imaging Fundus Photography, Optical Coherence Tomography OCT, Electrophysiological Testing Electroretinography, Visual Field Testing, Fundus Autofluorescence Imaging
6 By Therapy: Gene Therapy, Stem Cell Therapy, Retinal Prosthesis Artificial Retina, Pharmacological Therapy Gene Editing, Retinal Drugs, Photoreceptor Rescue Therapy

What Are The Regional Insights Into The Inherited Retinal Disease Market?
North America was the largest region in the inherited retinal disease market in 2024. However, the Asia-Pacific region is forecasted to experience the most rapid growth in the coming years. Other regions covered in the report include Western Europe, Eastern Europe, South America, the Middle East, and Africa.

Browse For More Similar Reports-

Vitreoretinal Surgery Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/vitreoretinal-surgery-devices-global-market-report

Retinal Biologics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/retinal-biologics-global-market-report

Retinal Disorder Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

Getting Known More About The Business Research Company
Renowned by over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company offers comprehensive data-rich research and insights. Armed with 1,500,000 datasets, their reports provide an in-depth secondary research and unique insights from industry leaders, helping stakeholders stay ahead in the game.

Connect with us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us: [email protected]

Stay connected:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.